Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Merck reveals new thrombin inhibitor series

Dec. 3, 1996

No Comments

3DP seeks partners for protease inhibitor discovery program

Nov. 29, 1996

No Comments

Merck & Co. reports nonpeptide fibrinogen antagonists with oral activity

Nov. 28, 1996

No Comments

Potent, orally active antiplatelet agent discovered by Merck & Co.

Nov. 28, 1996

No Comments

Natural antiplatelet agent discovered at Kitasato Institute

Nov. 28, 1996

No Comments

RESTORE trial results presented at AHA meeting

Nov. 22, 1996

No Comments

New market introduction for ReoPro

Nov. 22, 1996

No Comments

Antithrombotic/antiallergic agents from Terumo

Nov. 22, 1996

No Comments

Genetics Institute's factor IX scheduled for review

Nov. 21, 1996

No Comments

Clinical trial compares therapeutic potential of heparin and hirudin in coronary thrombosis

Nov. 21, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Hematologic, BioWorld Science
RSS

Merck reveals new thrombin inhibitor series

3DP seeks partners for protease inhibitor discovery program

Merck & Co. reports nonpeptide fibrinogen antagonists with oral activity

Potent, orally active antiplatelet agent discovered by Merck & Co.

Natural antiplatelet agent discovered at Kitasato Institute

RESTORE trial results presented at AHA meeting

New market introduction for ReoPro

Antithrombotic/antiallergic agents from Terumo

Genetics Institute's factor IX scheduled for review

Clinical trial compares therapeutic potential of heparin and hirudin in coronary thrombosis

Today's news in brief

Today's news in brief

Regulatory actions for Oct. 31, 2024

Nanocube’s nanorobots to revolutionize cancer diagnosis, treatment

Cureverse, Angelini ink $360M deal for oral Alzheimer’s drug

Hematologic, BioWorld Science RSS

Hematologic, BioWorld Science
RSS